Skip to main content

Table 3 Grade 3/4 hematological toxicity per cycle and per patient

From: Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma

Toxicity

% of 220 cycles

% of 40 patients

 

Grade 3

Grade 4

Grade 3

Grade 4

Neutropenia

20

10

35

15

Thrombocytopenia

1

-

2.5

-

Anemia

4

-

10

-

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us